
erythromycin stearate brand names and other generic formulations include:
No brand names available
flibanserin oral brand names and other generic formulations include:
Addyi Oral
erythromycin stearate and flibanserin oral
erythromycin stearate will increase the level or effect of flibanserin oral by altering drug metabolism. Flibanserin should not be combined with drugs that reduce the activity of liver enzymes that breakdown flibanserin. Such combinations increase the risk of severe low blood pressure and fainting.
erythromycin stearate and flibanserin oral
erythromycin stearate will increase the level or effect of flibanserin oral by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Coadministration of flibanserin with moderate or strong CYP3A4 inhibitors is contraindicated. Severe hypotension or syncope can occur.
Check for more interactions with the Drug Interaction Checker
Drug Interaction Categories
Contraindicated
Never use this combination of drugs because of high risk for dangerous interaction
Serious
Potential for serious interaction; regular monitoring by your doctor required or alternate medication may be needed
Significant
Potential for significant interaction (monitoring by your doctor is likely required)
Minor
Interaction is unlikely, minor, or nonsignificant